Revisiting Factor VIII cases: is it time for an agency adjudication system?
Su
Yi-Chen
YC
George Washington University Law School, USA.
D001771:Blood Banks / Q000331:legislation & jurisprudence*; D016913:Blood Component Transfusion / Q000009:adverse effects / Q000331:legislation & jurisprudence*; D001782:Blood Donors / Q000331:legislation & jurisprudence; D035881:Compensation and Redress / Q000331:legislation & jurisprudence*; D003257:Consumer Product Safety / Q000331:legislation & jurisprudence; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D005176:Factor XIII; D035082:Federal Government; D006078:Government Programs / Q000331:legislation & jurisprudence; D015658:HIV Infections / Q000097:blood / Q000635:transmission; D006467:Hemophilia A / Q000628:therapy / Q000821:virology; D006801:Humans; D007880:Legislation, Drug; D016365:Liability, Legal; D013219:State Government; D013624:Taiwan; D014481:United States; D014486:United States Food and Drug Administration
D005176:Factor XIII